Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Drug resistance among students with pulmonary tuberculosis: a study based on screening in Henan, China.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central, [2001-
    • الموضوع:
    • نبذة مختصرة :
      Competing Interests: Declarations. Human Ethics and Consent to Participate: Not applicable. Competing interests: The authors declare no competing interests.
      Background: Tuberculosis (TB) can easily spread among students and can lead to an outbreak once there is an infection in a school. Outbreaks of drug-resistant TB (DR-TB) in schools have occasionally been reported, but the profile of DR-TB in students in a province has rarely been described. This study was conducted to determine the prevalence of DR-TB and factors associated with it in students in Henan Province, China.
      Methods: We retrospectively reviewed the data of 3527 pulmonary TB patients among students with culture-confirmed Mycobacterium tuberculosis (M.tb) isolates collected from the Tuberculosis Information Management System of the China Disease Prevention and Control Information System from 2015 to 2021. Prevalence of DR-TB was analyzed. Comparisons between categorical variables were analyzed using the chi-square test or Fisher's exact test as appropriate. Logistic regression models were used to identify the factors associated with DR-TB.
      Results: Any DR-, RR (rifampin resistance)- and MDR (multi-drug resistance) -TB rates in students were 10.46%, 7.91% and 6.10%, respectively. And they all showed a downward trend from 2015 to 2021 (p < 0.001). Previously treated cases were 7.30 (95% CI: 5.30, 10.05), 8.60 (95% CI: 6.14,12.14) and 9.43 (95% CI: 6.64,13.40) times more likely than the new cases to be diagnosed with Any DR-TB, RR-TB and MDR-TB, respectively. Patients from schools in the western region of Henan had greater odds of having Any DR- (AOR = 2.06, 95% CI: 1.31, 3.24), RR- (AOR = 2.81, 95% CI: 1.66, 4.76) and MDR-TB (AOR = 2.07, 95% CI: 1.13, 3.80) than those from schools in the northern region. Males had a 1.40-fold (95% CI: 1.11, 1.78), 1.34-fold (95% CI: 1.02, 1.75) greater likelihood of being diagnosed with Any DR- and RR-TB, respectively. The risk of being diagnosed with MDR-TB was 1.42 (95% CI: 1.00, 2.02) times greater in students migrant between prefectures of the province than in the locals.
      Conclusion: The prevalence of DR-TB among students with PTB in Henan, China, significantly decreased from 2015 to 2021. Previous treated cases and those in west-region schools in Henan were at greater risk of being diagnosed with Any DR-, RR- and MDR-TB. In addition, males were more likely to be diagnosed with Any DR- and RR-TB. It requires further study that whether those who migrated between prefectures of the province were more likely to be diagnosed with MDR-TB.
      (© 2025. The Author(s).)
    • References:
      BMC Public Health. 2011 Feb 17;11:110. (PMID: 21324205)
      Front Public Health. 2023 Feb 09;11:1114248. (PMID: 36844836)
      Thorax. 2006 Feb;61(2):158-63. (PMID: 16254056)
      Western Pac Surveill Response J. 2021 Jan 26;12(1):1-5. (PMID: 34094617)
      BMC Public Health. 2013 Dec 13;13:1171. (PMID: 24330553)
      BMC Infect Dis. 2019 Apr 4;19(1):307. (PMID: 30947695)
      Euro Surveill. 2019 Jun;24(24):. (PMID: 31213222)
      Pol J Microbiol. 2020;69:1-5. (PMID: 32249555)
      BMC Infect Dis. 2019 Nov 14;19(1):972. (PMID: 31727001)
      Sci Rep. 2019 May 13;9(1):7315. (PMID: 31086215)
      PLoS One. 2022 Jun 16;17(6):e0270003. (PMID: 35709161)
      Trop Med Int Health. 2021 Jan;26(1):45-53. (PMID: 32997863)
      Trop Med Int Health. 2019 Apr;24(4):421-431. (PMID: 30663180)
      Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1210-1215. (PMID: 30236190)
      Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Jun 10;41(6):856-860. (PMID: 32564549)
      PLoS One. 2019 Nov 15;14(11):e0225042. (PMID: 31730664)
      Epidemiol Infect. 2022 Jan 28;150:e27. (PMID: 35086596)
      J Infect Dev Ctries. 2015 Oct 29;9(10):1076-85. (PMID: 26517482)
      Front Public Health. 2023 May 11;11:1156930. (PMID: 37250072)
      Ann Ist Super Sanita. 2019 Jan-Mar;55(1):55-58. (PMID: 30968837)
      Int J Tuberc Lung Dis. 2009 Feb;13(2):253-9. (PMID: 19146756)
      PLoS One. 2019 Jun 12;14(6):e0217597. (PMID: 31188848)
      J Infect. 2018 Dec;77(6):469-478. (PMID: 30339803)
      Croat Med J. 2021 Feb 28;62(1):90-94. (PMID: 33660965)
      J Appl Microbiol. 2020 Jun;128(6):1547-1567. (PMID: 31595643)
      Int J Tuberc Lung Dis. 2022 Sep 1;26(9):875-879. (PMID: 35996278)
      Infect Drug Resist. 2025 Jan 27;18:499-509. (PMID: 39898352)
      BMC Res Notes. 2017 Jan 3;10(1):8. (PMID: 28057041)
      Infect Dis Poverty. 2015 Mar 24;4:14. (PMID: 25806104)
      BMC Infect Dis. 2019 Sep 6;19(1):779. (PMID: 31492099)
      Korean J Intern Med. 2019 Mar;34(2):344-352. (PMID: 30045614)
    • Grant Information:
      212102310156 Henan Province Scientific Research Project; 212102310156 Henan Province Scientific Research Project; 212102310156 Henan Province Scientific Research Project; LHGJ20230624 Henan Province Medical Science and Technology Project; LHGJ20230624 Henan Province Medical Science and Technology Project; LHGJ20230624 Henan Province Medical Science and Technology Project; LHGJ20230624 Henan Province Medical Science and Technology Project; LHGJ20230624 Henan Province Medical Science and Technology Project; LHGJ20230624 Henan Province Medical Science and Technology Project; LHGJ20230624 Henan Province Medical Science and Technology Project; 2017ZX10201302-006 Key Project of Chinese National Programs
    • Contributed Indexing:
      Keywords: Drug resistance; Student; Tuberculosis
    • الرقم المعرف:
      0 (Antitubercular Agents)
    • الموضوع:
      Date Created: 20250808 Date Completed: 20250809 Latest Revision: 20250812
    • الموضوع:
      20250812
    • الرقم المعرف:
      PMC12333275
    • الرقم المعرف:
      10.1186/s12879-025-11408-1
    • الرقم المعرف:
      40781271